Overexpression of ANRIL has been found in several malignant tumors, and abnormally high expression of ANRIL was found to be related to tumor proliferative ability (Kong, Hsieh & Alonso, 2018), but there was no association between circANRIL and these pathways in this study. Here, CDKN2B-AS1 is linked to neoplasm.